Showing results (31-40 of 528) with videos related to
Sort By:
Pageof 53
Organic Letters|December 24, 2011
Solid-phase synthesis of NMe-IB-01212, a highly N-methylated cyclic peptideEleonora Marcucci, Judit Tulla-Puche, Fernando AlbericioMolecules (Basel, Switzerland)|February 14, 2020
The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMethods and Protocols|November 22, 2022
Practical Protocols for Solid-Phase Peptide Synthesis 4.0Beatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|March 8, 2017
The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule TypeBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 13, 2025
The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 15, 2022
The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioCurrent Drug Delivery|May 30, 2012
Polymers and drug delivery systemsGemma Vilar, Judit Tulla-Puche, Fernando AlbericioBiopolymers|November 13, 2008
Enhanced microwave-assisted method for on-bead disulfide bond formation: synthesis of alpha-conotoxin MIIAthanassios S Galanis, Fernando Albericio, Morten GrøtliOrganic Letters|March 13, 2015
Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistryIván Ramos-Tomillero, Hortensia Rodríguez, Fernando AlbericioMolecules (Basel, Switzerland)|March 3, 2018
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioPageof 53